| Lastest Insider Transactions Of Definium Therapeutics, Inc. ( DFTX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| DFTX | Definium Therapeutics, Inc. | Vallone Carol A | Directior | 2026-09-18 | Option Exercise | 1,086 | 35.52 | 38,575 | 2026-09-18 21:55:06 |
| DFTX | Definium Therapeutics, Inc. | Krebs Andreas | Directior | 2026-09-18 | Option Exercise | 1,629 | 35.52 | 57,862 | 2026-09-18 21:55:05 |
| DFTX | Definium Therapeutics, Inc. | Barrow Robert | Chief Executive Officer | 2026-09-02 | Sell | 19,023 | 37.94 | 721,733 | 2026-09-04 21:30:03 |
| DFTX | Definium Therapeutics, Inc. | Sullivan Mark | Chief Legal Officer | 2026-06-25 | Sell | 13,008 | 45.03 | 585,750 | 2026-06-26 16:30:10 |
| DFTX | Definium Therapeutics, Inc. | Roberts Brandi | Chief Financial Officer | 2026-06-25 | Sell | 3,013 | 45.03 | 135,675 | 2026-06-26 16:30:07 |
| DFTX | Definium Therapeutics, Inc. | Barrow Robert | Chief Executive Officer | 2026-06-25 | Sell | 29,208 | 45.03 | 1,315,236 | 2026-06-26 16:30:05 |
| DFTX | Definium Therapeutics, Inc. | Karlin Daniel | Chief Medical Officer | 2026-06-25 | Sell | 10,035 | 45.03 | 451,876 | 2026-06-26 16:30:04 |
| DFTX | Definium Therapeutics, Inc. | Wiley Matthew T. | Chief Commercial Officer | 2026-06-25 | Sell | 2,867 | 45.03 | 129,101 | 2026-06-26 16:30:03 |
| DFTX | Definium Therapeutics, Inc. | Karlin Daniel | Chief Medical Officer | 2026-03-25 | Sell | 8,018 | 18.47 | 148,092 | 2026-03-26 18:43:44 |
| DFTX | Definium Therapeutics, Inc. | Sullivan Mark | Chief Legal Officer | 2026-03-25 | Sell | 10,702 | 18.47 | 197,666 | 2026-03-26 18:42:48 |
| DFTX | Definium Therapeutics, Inc. | Barrow Robert | Chief Executive Officer | 2026-03-25 | Sell | 24,431 | 18.47 | 451,241 | 2026-03-26 18:42:23 |
